| Literature DB >> 20226436 |
Pierre-Emmanuel Morange1, Irene Bezemer, Noémie Saut, Lance Bare, Gwenaelle Burgos, Jessy Brocheton, Hervé Durand, Christine Biron-Andreani, Jean-Francois Schved, Gilles Pernod, Pilar Galan, Ludovic Drouet, Diana Zelenika, Marine Germain, Viviane Nicaud, Simon Heath, Ewa Ninio, Aurélien Delluc, Thomas Münzel, Tanja Zeller, Stefan-Martin Brand-Herrmann, Marie-Christine Alessi, Laurence Tiret, Mark Lathrop, François Cambien, Stefan Blankenberg, Joseph Emmerich, David-Alexandre Trégouët, Frits R Rosendaal.
Abstract
To identify genetic susceptibility factors conferring increased risk of venous thrombosis (VT), we conducted a multistage study, following results of a previously published GWAS that failed to detect loci for developing VT. Using a collection of 5862 cases with VT and 7112 healthy controls, we identified the HIVEP1 locus on chromosome 6p24.1 as a susceptibility locus for VT. Indeed, the HIVEP1 rs169713C allele was associated with an increased risk for VT, with an odds ratio of 1.20 (95% confidence interval 1.13-1.27, p = 2.86 x 10(-9)). HIVEP1 codes for a protein that participates in the transcriptional regulation of inflammatory target genes by binding specific DNA sequences in their promoter and enhancer regions. The current results provide the identification of a locus involved in VT susceptibility that lies outside the traditional coagulation/fibrinolysis pathway. (c) 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20226436 PMCID: PMC2850428 DOI: 10.1016/j.ajhg.2010.02.011
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025